High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
Clinical trial NCT03494270 · COMPLETED
Trial details
- NCT number
- NCT03494270
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-18
- Primary completion
- 2019-09-26
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.